Cite

HARVARD Citation

    Apperley, J. et al. (n.d.). P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) FROM THE PACE AND OPTIC TRIALS. HemaSphere. pp. 602-603. [Online]. 
  
Back to record